Annual Total Liabilities
$269.68 M
+$210.84 M+358.32%
December 31, 2024
Summary
- As of March 12, 2025, VRNA annual total liabilities is $269.68 million, with the most recent change of +$210.84 million (+358.32%) on December 31, 2024.
- During the last 3 years, VRNA annual total liabilities has risen by +$231.10 million (+598.99%).
- VRNA annual total liabilities is now at all-time high.
Performance
VRNA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$269.68 M
+$18.36 M+7.30%
December 31, 2024
Summary
- As of March 12, 2025, VRNA quarterly total liabilities is $269.68 million, with the most recent change of +$18.36 million (+7.30%) on December 31, 2024.
- Over the past year, VRNA quarterly total liabilities has increased by +$210.84 million (+358.32%).
- VRNA quarterly total liabilities is now at all-time high.
Performance
VRNA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
VRNA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +358.3% | +358.3% |
| 3 y3 years | +599.0% | +358.3% |
| 5 y5 years | +1898.7% | +358.3% |
VRNA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +829.9% | at high | +832.0% |
| 5 y | 5-year | at high | +1898.7% | at high | +2071.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Verona Pharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $269.68 M(+358.3%) | $269.68 M(+7.3%) |
| Sep 2024 | - | $251.33 M(-5.5%) |
| Jun 2024 | - | $265.85 M(+309.5%) |
| Mar 2024 | - | $64.92 M(+10.3%) |
| Dec 2023 | $58.84 M(+102.9%) | $58.84 M(+103.3%) |
| Sep 2023 | - | $28.94 M(-6.2%) |
| Jun 2023 | - | $30.84 M(-33.5%) |
| Mar 2023 | - | $46.40 M(+60.0%) |
| Dec 2022 | $29.00 M(-24.8%) | $29.00 M(-22.4%) |
| Sep 2022 | - | $37.39 M(-15.0%) |
| Jun 2022 | - | $43.98 M(+2.3%) |
| Mar 2022 | - | $43.01 M(+11.5%) |
| Dec 2021 | $38.58 M(+99.4%) | $38.58 M(+15.7%) |
| Sep 2021 | - | $33.36 M(-48.0%) |
| Jun 2021 | - | $64.11 M(+261.4%) |
| Mar 2021 | - | $17.74 M(-8.4%) |
| Dec 2020 | $19.35 M(+43.4%) | $19.35 M(-59.8%) |
| Sep 2020 | - | $48.11 M(+18.2%) |
| Jun 2020 | - | $40.72 M(+227.9%) |
| Mar 2020 | - | $12.42 M(-8.0%) |
| Dec 2019 | $13.49 M(-6.1%) | $13.49 M(-23.1%) |
| Sep 2019 | - | $17.54 M(+27.4%) |
| Jun 2019 | - | $13.77 M(+49.0%) |
| Mar 2019 | - | $9.24 M(-35.7%) |
| Dec 2018 | $14.37 M | $14.37 M(-3.8%) |
| Sep 2018 | - | $14.94 M(-17.4%) |
| Jun 2018 | - | $18.09 M(-25.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $24.26 M(+86.6%) |
| Dec 2017 | $13.00 M(-9.7%) | $13.00 M(+0.3%) |
| Sep 2017 | - | $12.97 M(+10.1%) |
| Jun 2017 | - | $11.78 M(-18.2%) |
| Dec 2016 | $14.40 M(+304.0%) | $14.40 M(+753.5%) |
| Jun 2016 | - | $1.69 M(-52.7%) |
| Dec 2015 | $3.57 M(+336.9%) | $3.57 M(+296.9%) |
| Jun 2015 | - | $898.30 K(+10.1%) |
| Dec 2014 | $816.10 K(+1.1%) | $816.10 K(+18.2%) |
| Jun 2014 | - | $690.40 K(-14.4%) |
| Dec 2013 | $806.90 K(+150.5%) | $806.90 K(+204.1%) |
| Jun 2013 | - | $265.30 K(-17.6%) |
| Dec 2012 | $322.10 K(+33.0%) | $322.10 K(+105.0%) |
| Jun 2012 | - | $157.10 K(-35.1%) |
| Dec 2011 | $242.20 K(-23.8%) | $242.20 K(-47.3%) |
| Jun 2011 | - | $459.70 K(+44.6%) |
| Dec 2010 | $317.90 K(-31.5%) | $317.90 K(+225.1%) |
| Jun 2010 | - | $97.80 K(-78.9%) |
| Dec 2009 | $464.10 K(+277.3%) | $464.10 K(+394.8%) |
| Jun 2009 | - | $93.80 K(-23.7%) |
| Dec 2008 | $123.00 K(-60.5%) | $123.00 K(-79.0%) |
| Jun 2008 | - | $587.10 K(+88.5%) |
| Dec 2007 | $311.40 K(+140.8%) | $311.40 K(+121.5%) |
| Jun 2007 | - | $140.60 K(+8.7%) |
| Dec 2006 | $129.30 K(+527.7%) | $129.30 K(-47.8%) |
| Jun 2006 | - | $247.60 K(+1101.9%) |
| Dec 2005 | $20.60 K | $20.60 K(+64.8%) |
| Jun 2005 | - | $12.50 K |
FAQ
- What is Verona Pharma annual total liabilities?
- What is the all time high annual total liabilities for Verona Pharma?
- What is Verona Pharma annual total liabilities year-on-year change?
- What is Verona Pharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Verona Pharma?
- What is Verona Pharma quarterly total liabilities year-on-year change?
What is Verona Pharma annual total liabilities?
The current annual total liabilities of VRNA is $269.68 M
What is the all time high annual total liabilities for Verona Pharma?
Verona Pharma all-time high annual total liabilities is $269.68 M
What is Verona Pharma annual total liabilities year-on-year change?
Over the past year, VRNA annual total liabilities has changed by +$210.84 M (+358.32%)
What is Verona Pharma quarterly total liabilities?
The current quarterly total liabilities of VRNA is $269.68 M
What is the all time high quarterly total liabilities for Verona Pharma?
Verona Pharma all-time high quarterly total liabilities is $269.68 M
What is Verona Pharma quarterly total liabilities year-on-year change?
Over the past year, VRNA quarterly total liabilities has changed by +$210.84 M (+358.32%)